Abstract
Autonomic and hypothalamic modulation of glucose uptake in skeletal muscle 130 Skeletal muscle is a critical tissue responsible for insulin-stimulated glucose uptake in 131 response to feeding. Under normal conditions, hyperglycemia triggers insulin secretion and 132 increases glucose uptake in skeletal muscle; however, this ability is markedly impaired in the 133 condition of insulin resistance, which is characteristically displayed in type-2 diabetes and 134 also frequently seen in obesity (61, 76). The hypothalamus plays a significant role in 135 affecting glucose update of skeletal muscle via the sympathetic nervous system and probably 136 through insulin-independent pathways (86, 115). For instance, the intra-cerebral ventricular 137 injection of leptin into the hypothalamic third ventricle leads to an increase in muscle glucose 138 uptake, and this effect was shown to be dependent on β-adrenergic activation (81) and 139 mediated through an insulin-independent mechanism (49). Furthermore, electrical stimulation 140 of the ventromedial hypothalamus resulted in the increased uptake of glucose by skeletal 141 muscle through sympathetic action, with this result also being independent of insulin 142 8 signaling (119). In addition, injection of orexin-A into the ventral hypothalamic region was 143 found to cause sympathetic excitation, leading to an increase in muscle glucose uptake (120).
144
Finally, much of the sympathetic activation that regulates skeletal muscle glucose uptake 145 appears to be regulated through norepinephrine signaling (86). To summarize, the 146 hypothalamus has effects on glucose uptake and utilization in skeletal muscles through 147 insulin-independent autonomic activation, and this effect might provide an appreciable 148 contribution to the control of glucose homeostasis under certain physiological conditions. The pancreas, including islets, is richly innervated by both the sympathetic and 
